These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 37662929)

  • 1. Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma.
    Jiang S; Dong Y; Wang J; Zhang X; Liu W; Wei Y; Zhou H; Shen L; Yang J; Zhu Q
    Front Immunol; 2023; 14():1207061. PubMed ID: 37662929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma.
    Zhou S; Lu Y; Chen Y; Gan W
    Sci Rep; 2023 Mar; 13(1):4449. PubMed ID: 36932108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model based on immunogenic cell death-related genes predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma.
    Dong P; Zhao L; Zhao L; Zhang J; Lu G; Zhang H; Ma M
    Transl Cancer Res; 2024 Jan; 13(1):249-267. PubMed ID: 38410237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and validation of a model based on immunogenic cell death-associated lncRNAs to predict prognosis and direct therapy for kidney renal clear cell carcinoma.
    Cai C; Shu K; Chen W; Ding J; Guo Z; Wei Y; Zhang W
    Aging (Albany NY); 2023 Jun; 15(12):5304-5338. PubMed ID: 37379129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma.
    Cai Z; He Y; Yu Z; Hu J; Xiao Z; Zu X; Li Z; Li H
    Front Immunol; 2022; 13():933241. PubMed ID: 36211378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
    Han S; Wang Q; Shen M; Zhang X; Wang J
    Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel immunogenic cell death-related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer.
    Dong B; Wu Y; Zhang J; Gu Y; Xie R; He X; Pang X; Wang X; Cui Y
    Front Immunol; 2023; 14():1162876. PubMed ID: 37215130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
    Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
    Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
    [No Abstract]   [Full Text] [Related]  

  • 9. Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma.
    Cui Y; Li Y; Long S; Xu Y; Liu X; Sun Z; Sun Y; Hu J; Li X
    BMC Med Genomics; 2023 Aug; 16(1):184. PubMed ID: 37553698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.
    Kuang Y; Jiang B; Zhu H; Zhou Y; Huang H; Li C; Zhang W; Li X; Cao Y
    Front Immunol; 2023; 14():1102094. PubMed ID: 37153540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel immune-related signature based on immune cells for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Jun; 36(6):e24409. PubMed ID: 35441741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing.
    Chen X; Zhang Z; Qin Z; Zhu X; Wang K; Kang L; Li C; Wang H
    Aging (Albany NY); 2024 Mar; 16(6):5676-5702. PubMed ID: 38517387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunogenic cell death-related signature predicts prognosis and immunotherapy response in stomach adenocarcinoma.
    Liu Z; Sun L; Peng X; Liu S; Zhu Z; Huang C
    Apoptosis; 2023 Dec; 28(11-12):1564-1583. PubMed ID: 37580435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive analysis of immunogenic cell death and its key gene HSP90AA1 in bladder cancer.
    Song Q; Zhou Z; Bai J; Liu N
    Clin Transl Oncol; 2023 Aug; 25(8):2587-2606. PubMed ID: 37000291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma.
    Zheng A; Bai J; Ha Y; Yu Y; Fan Y; Liang M; Lu Y; Shen Z; Luo B; Jie W
    BMC Cancer; 2023 Feb; 23(1):135. PubMed ID: 36759775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.
    Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X
    BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell combined bioinformatics analysis: construction of immune cluster and risk prognostic model in kidney renal clear cells based on CD8
    Gao H; Sun H; He A; Liu H; Zhang Z; Li D; Mao W; Qian J
    Eur J Med Res; 2024 Jan; 29(1):89. PubMed ID: 38291496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene set enrichment analysis identifies immune subtypes of kidney renal clear cell carcinoma with significantly different molecular and clinical properties.
    Chen Z; Cao W; Luo J; Abdelrahman Z; Lu Q; Wang H; Wang X
    Front Immunol; 2023; 14():1191365. PubMed ID: 37426638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework.
    Liu J; Shi Y; Zhang Y
    EPMA J; 2023 Jun; 14(2):275-305. PubMed ID: 37275552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.